GEN
Generate Biomedicines, Inc.
Stock
Stock
Ticker: GENB
GENB
Price
Price
CHART BY
Frequently asked questions
What is Generate Biomedicines, Inc.'s market capitalization?
The market capitalization of Generate Biomedicines, Inc. is $1.68B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What are the analyst ratings and target price for Generate Biomedicines, Inc.'s stock?
Currently, 6 analysts cover Generate Biomedicines, Inc.'s stock, with a consensus target price of $27.00. Analyst ratings provide insights into the stock's expected performance.
How many employees does Generate Biomedicines, Inc. have, and what sector and industry does it belong to?
Generate Biomedicines, Inc. employs approximately 312 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Generate Biomedicines, Inc.'s shares?
The free float of Generate Biomedicines, Inc. is 55.21M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.68B
- Free Float
- 55.21M
Pricing
- 52W span
- $11.00$22.60
Analyst Ratings
The price target is $27.00 and the stock is covered by 6 analysts.
Buy
6
Hold
0
Sell
0
Information
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
- Employees
- 312
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- Primary Ticker
- GENB
Fundamentals & EOD data from FactSet